𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan nanoparticles

✍ Scribed by Lifeng Qi; Zirong Xu; Minli Chen


Book ID
116429158
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
587 KB
Volume
43
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Suppression of growth of hepatocellular
✍ Hidenao Yamamoto; Jiro Fujimoto; Eizo Okamoto; Jun-ichi Furuyama; Taiki Tamaoki; πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 146 KB πŸ‘ 1 views

Treatment of HuH-7 human hepatocellular carcinoma (HCC) cells with 1-10 mM sodium butyrate (SB) resulted in growth inhibition in a dose-dependent manner. At 3 mM and higher concentrations, SB caused nuclear fragmentation and DNA ladder formation characteristic of apoptosis. In the treated cells, the

Troglitazone inhibits tumor growth in he
✍ Jun Yu; Liang Qiao; Lars Zimmermann; Matthias P. A. Ebert; Hongxia Zhang; Wendy πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 513 KB

Peroxisome proliferator-activated receptor gamma (PPARgamma) has been implicated in the differentiation and growth inhibition of cancer cells. We examined the effects of PPARgamma activation by troglitazone on hepatocellular carcinoma (HCC) cell growth, proliferation, and apoptosis in vitro and in v

Soluble glypican 3 inhibits the growth o
✍ Sandra I. Zittermann; Mariana I. Capurro; Wen Shi; Jorge Filmus πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 695 KB

## Abstract The heterogeneity of the molecular pathology of HCC poses a formidable obstacle to the development of non‐cytotoxic therapies. Several pro‐tumorigenic signaling pathways can be aberrantly activated in HCC, including those triggered by Wnts. Glypican‐3 (GPC3), a membrane‐bound heparan su